Fabiani, Emiliano
 Distribuzione geografica
Continente #
EU - Europa 1.939
NA - Nord America 1.751
AS - Asia 648
SA - Sud America 17
AF - Africa 15
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.378
Nazione #
US - Stati Uniti d'America 1.741
DE - Germania 830
SE - Svezia 385
CN - Cina 375
UA - Ucraina 161
SG - Singapore 127
IT - Italia 121
PL - Polonia 106
FR - Francia 98
IE - Irlanda 66
IN - India 47
GB - Regno Unito 46
ID - Indonesia 41
FI - Finlandia 39
RU - Federazione Russa 29
JP - Giappone 13
NL - Olanda 11
TR - Turchia 11
BE - Belgio 10
CA - Canada 9
CI - Costa d'Avorio 9
KR - Corea 9
BR - Brasile 7
AU - Australia 6
IR - Iran 6
VN - Vietnam 6
CO - Colombia 5
CZ - Repubblica Ceca 5
AT - Austria 4
BG - Bulgaria 4
ES - Italia 4
CH - Svizzera 3
GR - Grecia 3
HK - Hong Kong 3
NO - Norvegia 3
TH - Thailandia 3
ZA - Sudafrica 3
HR - Croazia 2
LT - Lituania 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BO - Bolivia 1
CL - Cile 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
MX - Messico 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 4.378
Città #
Chandler 352
Jacksonville 118
Warsaw 105
Singapore 104
Ashburn 103
Dearborn 92
Nanjing 85
Houston 82
San Mateo 78
Ann Arbor 72
Dublin 61
Woodbridge 55
Wilmington 53
New York 50
Fairfield 43
Nürnberg 41
Jakarta 39
Bremen 38
Milan 35
Nanchang 31
Seattle 30
Beijing 29
Lawrence 27
Redwood City 27
Moscow 25
Munich 23
Boston 22
Marseille 20
Cattolica 18
Shanghai 18
Chatsworth 16
Kunming 16
Hangzhou 15
Los Angeles 15
Leawood 14
Auburn Hills 13
Changsha 13
Guangzhou 13
Hefei 13
Zhengzhou 13
Shenyang 12
Cambridge 11
Princeton 11
Pune 11
Chicago 10
Mountain View 10
Tianjin 10
Abidjan 9
Brussels 9
Jiaxing 9
Rome 9
University Park 9
Augusta 8
Fremont 8
Hebei 8
Izmir 8
Jinan 8
Lanzhou 7
Boardman 6
Edinburgh 6
Enterprise 6
Helsinki 6
London 6
Washington 6
Costa Mesa 5
Frankfurt am Main 5
Hanoi 5
Monmouth Junction 5
Norwalk 5
Paris 5
Simi Valley 5
Atlanta 4
Lancaster 4
Medellín 4
San Jose 4
Seo-gu 4
Seoul 4
Andover 3
Cape Town 3
Chengdu 3
Dallas 3
Falls Church 3
Hong Kong 3
Indiana 3
New Delhi 3
Oslo 3
Philadelphia 3
Phoenix 3
Redmond 3
Richardson 3
San Diego 3
São Paulo 3
Taizhou 3
Tokyo 3
Toronto 3
Vienna 3
Örebro 3
Barcelona 2
Bologna 2
Buffalo 2
Totale 2.345
Nome #
Fanconi anemia gene variants in therapy-related myeloid neoplasms 259
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 206
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 178
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 169
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 159
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 141
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 140
Why methylation is not a marker predictive of response to hypomethylating agents 137
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 135
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 134
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 134
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 134
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 128
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 124
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 124
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 121
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 116
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 115
Epigenetic changes in therapy-related MDS/AML 108
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 108
Similarities and differences between therapy-related and elderly acute myeloid leukemia 107
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 104
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 103
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 103
PU.1 and CEBPA expression in acute myeloid leukemia. 98
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 96
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 91
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 90
Clonal evolution in therapy-related neoplasms 90
Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia 83
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 80
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 80
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 79
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 78
Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy 70
Therapy-related myeloid neoplasms: Clinical perspectives 61
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 59
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells 49
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 17
Totale 4.408
Categoria #
all - tutte 14.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020256 0 0 0 0 0 0 52 22 62 38 40 42
2020/2021546 18 37 10 38 57 59 93 7 47 45 114 21
2021/2022392 45 39 5 11 31 19 5 76 17 40 49 55
2022/2023954 140 144 77 181 56 99 36 93 76 3 36 13
2023/2024378 21 95 10 15 18 95 5 15 5 7 45 47
2024/2025237 19 22 70 22 80 15 9 0 0 0 0 0
Totale 4.408